Alx Oncology Holdings annual total debt
2019
2021
2022
2023
2024
2025
Alx Oncology Holdings Total Debt Growth & History (ALXO)
Alx Oncology Holdings's total debt was $14.8M for fiscal 2025.
View full Alx Oncology Holdings company overviewAlx Oncology Holdings annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.8M | −$2.2M | −13.01% |
| 2024 | 2024-12-31 | $17.0M | −$219,000 | −1.27% |
| 2023 | 2023-12-31 | $17.2M | $1.5M | +9.55% |
| 2022 | 2022-12-31 | $15.7M | $13.0M | +476.28% |
| 2021 | 2021-12-31 | $2.7M | — | — |
| 2019 | 2019-12-31 | $5.4M | — | — |
Alx Oncology Holdings quarterly total debt
Q4.19
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.0M | −$5.1M | −31.79% |
| Q1 2026 | 2026-03-31 | $13.0M | −$3.5M | −21.33% |
| Q4 2025 | 2025-12-31 | $14.8M | −$2.2M | −13.01% |
| Q3 2025 | 2025-09-30 | $15.6M | −$1.8M | −10.09% |
| Q2 2025 | 2025-06-30 | $16.2M | −$1.3M | −7.38% |
| Q1 2025 | 2025-03-31 | $16.6M | −$257,000 | −1.53% |
| Q4 2024 | 2024-12-31 | $17.0M | −$219,000 | −1.27% |
| Q3 2024 | 2024-09-30 | $17.4M | $2.3M | +15.50% |
| Q2 2024 | 2024-06-30 | $17.5M | $2.3M | +15.26% |
| Q1 2024 | 2024-03-31 | $16.8M | $1.4M | +8.90% |
| Q4 2023 | 2023-12-31 | $17.2M | $1.5M | +9.55% |
| Q3 2023 | 2023-09-30 | $15.0M | $8.4M | +127.16% |
| Q2 2023 | 2023-06-30 | $15.2M | $8.3M | +121.49% |
| Q1 2023 | 2023-03-31 | $15.5M | $9.6M | +165.74% |
| Q4 2022 | 2022-12-31 | $15.7M | $13.0M | +476.28% |
| Q3 2022 | 2022-09-30 | $6.6M | $3.7M | +127.12% |
| Q2 2022 | 2022-06-30 | $6.8M | $3.9M | +129.97% |
| Q1 2022 | 2022-03-31 | $5.8M | $5.3M | +993.98% |
| Q4 2021 | 2021-12-31 | $2.7M | — | — |
| Q3 2021 | 2021-09-30 | $2.9M | −$2.8M | −49.43% |
| Q2 2021 | 2021-06-30 | $3.0M | −$2.7M | −47.25% |
| Q1 2021 | 2021-03-31 | $532,000 | — | — |
| Q3 2020 | 2020-09-30 | $5.8M | — | — |
| Q2 2020 | 2020-06-30 | $5.6M | — | — |
| Q4 2019 | 2019-12-31 | $5.4M | — | — |
Alx Oncology Holdings total debt trends
Between the periods ended 2019-12-31 and 2025-12-31, Alx Oncology Holdings's total debt increased from $5.4M to $14.8M, a change of $9.3M. The latest reported quarter, Q2 2026, shows $11.0M.
About the metric
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
Calculation and source
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alx Oncology Holdings source filings ↗